MT
EW icon

Midwest Trust’s Edwards Lifesciences EW Stock Holding History

Midwest Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Sell
2,451
-693
-22% -$58.1K ﹤0.01% 584
2026
Q1 		$252K Sell
3,144
-224
-7% -$18.5K ﹤0.01% 543
2025
Q4 		$287K Sell
3,368
-14
-0.4% -$1.15K ﹤0.01% 517
2025
Q3 		$263K Buy
3,382
+14
+0.4% +$1.09K ﹤0.01% 530
2025
Q2 		$263K Buy
+3,368
New +$251K ﹤0.01% 540

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Midwest Trust's EW Position: Q2 2026 in Review

Midwest Trust reduced its Edwards Lifesciences (EW) stake by 22% in Q2 2026, selling an estimated $58.1K and leaving 2,451 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Midwest Trust first reported a position in EW in Q2 2025 and has held it in 5 quarters since. The position peaked at $287K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Midwest Trust held 2,451 shares of Edwards Lifesciences worth $222K as of Q2 2026.
  • Midwest Trust sold 693 Edwards Lifesciences shares in Q2 2026, an estimated $58.1K.
  • Edwards Lifesciences made up ﹤0.01% of Midwest Trust's portfolio in Q2 2026, its #584 holding.
  • Midwest Trust first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • Midwest Trust's Edwards Lifesciences position peaked at $287K in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.